Towards Healthcare
Liquid Biopsy IVD Market Drives USD 8.72 Billion by 2034

Liquid Biopsy IVD Market Size 2025 Clinical Labs and Blood Sample Testing Fuel Rapid Global Expansion

Market insights predict the global liquid biopsy IVD industry will increase from USD 2.21 billion in 2024 to USD 8.72 billion by 2034, achieving a CAGR of 14.79%. The liquid biopsy IBD market is growing due to the rising cases of cancer. North America is leading the market due to the focus on early diagnosis to prevent healthcare complications and costs.

  • Insight Code: 5961
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The liquid biopsy IVD market is projected to reach USD 8.72 billion by 2034, growing at a CAGR of 14.79% from 2024 to 2034.

North America is currently leading the liquid biopsy IVD market due to rising startups in cancer diagnostics.

The liquid biopsy IVD market includes 6 segments biomarker type, technology, application, sample type, end-user, and region.

Key trends include rising cancer cases and investment in cancer research.

The turnaround time for liquid biopsy results is around one week, which is two to three times faster than the time it takes for tissue biopsies to yield genetic information.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, National Cancer Institute, FDA, WHO, PIB, CDC.